Literature DB >> 19455050

Buerger's disease and anticardiolipin antibodies.

José Maria Pereira de Godoy1, Domingo Marcolino Braile.   

Abstract

Thromboangiitis obliterans or Buerger's disease is an occlusive, inflammatory, nonatherosclerotic vascular disease of unknown etiology, which affects mainly the small and medium arteries, veins and nerves. Anticardiolipin antibodies are associated with arterial and venous thrombosis, repetitive miscarriages and thrombocytopenia. The aim of this study is to bring to attention the diagnosis of Buerger's disease when found in conjunction with anticardiolipin antibodies. Three clinical cases that satisfy Shionoya's criteria for Buerger's disease (except the lack of smoking in one of the cases) are documented in this work. The following examinations were performed: hemogram, creatinine, glycemia, cholesterol, anticardiolipin antibodies, echocardiogram and angiogram. Shionoya's criteria for Buerger's disease were compatible with the two diseases: anticardiolipin antibody syndrome and Buerger's disease, both of which can occur in isolation or associated, thereby complicating the diagnosis. It is concluded that anticardiolipin can be associated with Buerger's disease and may worsen the thrombotic event of the disease but the two entities are separate. The diagnosis is not complicated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19455050     DOI: 10.2459/JCM.0b013e32832ce8d0

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  3 in total

1.  Investigation of the Etiology of Anemia in Thromboangiitis Obliterans.

Authors:  Mohammad Mehdi Akbarin; Hassan Ravari; Ataollah Rajabnejad; Narges Valizadeh; Bahare Fazeli
Journal:  Int J Angiol       Date:  2016-01-12

Review 2.  Buerger's disease: providing integrated care.

Authors:  Peter Klein-Weigel; Theresa Sophie Volz; Leonora Zange; Jutta Richter
Journal:  J Multidiscip Healthc       Date:  2016-10-12

3.  Thromboangiitis obliterans in two brothers.

Authors:  Qi-Lin Li; Dan-Hua He; Yong-Hua Huang; Mu Niu
Journal:  Exp Ther Med       Date:  2013-06-14       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.